Bart M. Wensing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bart M. Wensing has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Matthias Adrianus Wilhelmus Merkx
Department of Oral and Maxillofacial Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands
4 shared publications H.A.M. Marres
2 shared publicationsHenri A. M. Marres
Department of Otorhinolaryngology–Head and Neck Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
2 shared publicationsErnst J. Postema
Nuclear Medicine, Radboud University Nijmegen Medical Centre, The Netherlands
1 shared publicationF.J.A. Van Den Hoogen
1 shared publicationF.J.A. van Den Hoogen
1 shared publication
Latest Publications
- 1 November 2011
- Published by Elsevier in Oral Oncology
- Vol. 47 (11) , 1079-1084
Diagnostic value of magnetic resonance lymphography in preoperative staging of clinically negative necks in squamous cell carcinoma of the oral cavity: A pilot study
- 1 November 2011
- Published by Elsevier in Oral Oncology
- Vol. 47 (11) , 1079-1084
Diagnostic value of magnetic resonance lymphography in preoperative staging of clinically negative necks in squamous cell carcinoma of the oral cavity: A pilot study
- 29 November 2010
- Published by Wiley in Head & Neck
- Vol. 33 (10) , 1400-1405
Oral squamous cell carcinoma and a clinically negative neck: The value of follow‐up
Background: In squamous cell carcinoma of the oral cavity (SCCOC), regular follow‐up comprises 5 years of prescheduled visits, irrespective of tumor stage/classification and/or treatment. We analyzed our standard treatment and follow‐up protocol in patients with a preoperative clinically negative neck (cN0) in SCCOC.Methods: This is a retrospective chart analysis. Inventarization of treatment, occult metastatic spread, and follow‐up were performed.Results: In all, 197 patients were included. The occult metastatic rate was 24%. Eighty‐three percent of recurrent disease presented within 2 years. Fifty‐three percent of the patients with recurrent disease visited their physician outside prescheduled control visits.Conclusions: Ultrasound‐guided fine‐needle aspiration cytology currently is 1 of the most reliable staging techniques in cN0 SCCOC. Regular follow‐up could perhaps be limited from 5 to 2 years of prescheduled follow‐up visits. © 2010 Wiley Periodicals, Inc. Head Neck, 2010
- 29 November 2010
- Published by Wiley in Head & Neck
- Vol. 33 (10) , 1400-1405
Oral squamous cell carcinoma and a clinically negative neck: The value of follow‐up
Background: In squamous cell carcinoma of the oral cavity (SCCOC), regular follow‐up comprises 5 years of prescheduled visits, irrespective of tumor stage/classification and/or treatment. We analyzed our standard treatment and follow‐up protocol in patients with a preoperative clinically negative neck (cN0) in SCCOC.Methods: This is a retrospective chart analysis. Inventarization of treatment, occult metastatic spread, and follow‐up were performed.Results: In all, 197 patients were included. The occult metastatic rate was 24%. Eighty‐three percent of recurrent disease presented within 2 years. Fifty‐three percent of the patients with recurrent disease visited their physician outside prescheduled control visits.Conclusions: Ultrasound‐guided fine‐needle aspiration cytology currently is 1 of the most reliable staging techniques in cN0 SCCOC. Regular follow‐up could perhaps be limited from 5 to 2 years of prescheduled follow‐up visits. © 2010 Wiley Periodicals, Inc. Head Neck, 2010
- 28 February 2010
- Published by Elsevier in Oral Oncology
- Vol. 46 (2) , 87-91
Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma
- 28 February 2010
- Published by Elsevier in Oral Oncology
- Vol. 46 (2) , 87-91
Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma
- 1 May 2006
- Published by Wiley in The Laryngoscope
- Vol. 116 (5) , 809-813
FDG‐PET in the Clinically Negative Neck in Oral Squamous Cell Carcinoma
Objective: With improved diagnostic imaging techniques, it remains difficult to reduce occult metastatic disease in oral squamous cell carcinoma (SCC) to less than 20%. Therefore, supraomohyoid neck dissection (SOHND) still is a valuable staging procedure in these patients.Methods: Patients with clinically and ultrasonographically staged cN0 SCC of the oral cavity underwent FDG‐PET before SOHND. Histologic examination of neck dissection specimens was used as a “gold standard.”Results: Twenty‐eight consecutive patients were included, representing 30 necks. Occult metastatic disease was found in 30% of SOHND specimens. Average diameter of metastatic deposits was 4.3 mm. Sensitivity, specificity, and accuracy of FDG‐PET was 33%, 76%, and 63%, respectively.Conclusions: In patients with cN0 SCC of the oral cavity, FDG‐PET does not contribute to the preoperative workup. FDG‐PET does not replace SOHND as a staging procedure.
- 1 May 2006
- Published by Wiley in The Laryngoscope
- Vol. 116 (5) , 809-813
FDG‐PET in the Clinically Negative Neck in Oral Squamous Cell Carcinoma
Objective: With improved diagnostic imaging techniques, it remains difficult to reduce occult metastatic disease in oral squamous cell carcinoma (SCC) to less than 20%. Therefore, supraomohyoid neck dissection (SOHND) still is a valuable staging procedure in these patients.Methods: Patients with clinically and ultrasonographically staged cN0 SCC of the oral cavity underwent FDG‐PET before SOHND. Histologic examination of neck dissection specimens was used as a “gold standard.”Results: Twenty‐eight consecutive patients were included, representing 30 necks. Occult metastatic disease was found in 30% of SOHND specimens. Average diameter of metastatic deposits was 4.3 mm. Sensitivity, specificity, and accuracy of FDG‐PET was 33%, 76%, and 63%, respectively.Conclusions: In patients with cN0 SCC of the oral cavity, FDG‐PET does not contribute to the preoperative workup. FDG‐PET does not replace SOHND as a staging procedure.